Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "avtor" (Le��ai�� Luka) .

101 - 110 / 132
Na začetekNa prejšnjo stran567891011121314Na naslednjo stranNa konec
101.
The effect of bedrock and species mixture on wood density and radial wood increment in pubescent oak and black pine
Luka Krajnc, Polona Hafner, Jožica Gričar, 2020, izvirni znanstveni članek

Povzetek: Wood density and radial wood increment were examined in trees of pubescent oak (Quercus pubescens Willd.) and black pine (Pinus nigra Arnold., subsp. nigra) in relation to stand mixture and underlying bedrock. Trees of both species from pure and mixed stands were sampled across two types of bedrock, limestone and flysch. Trees from each species were similar in age. Wood density was estimated in standing trees using resistance drilling and increment cores were taken from a smaller subsample of trees of both species. Tree-ring, earlywood and latewood widths were measured and compared to radial profiles of wood density. The influence of stand mixture, diameter at breast height and bedrock on wood density was examined using a Bayesian general linear model. Wood density was significantly higher in pubescent oak than in black pine. Stand mixture was found to affect wood density positively, although the magnitude of the effect was relatively small when compared to other influencing factors also included in the current study. The effect of diameter on wood density was positive on both bedrocks in pubescent oak and negative or neutral in black pine. The size of the effect varied by bedrock and species. On flysch bedrock, the influence of diameter on wood density was stronger than it was on limestone. These indirect bedrock effects on wood density are probably a result of different soil fertility rather than the bedrock itself. There was a notable difference in radial wood increment in both species across the two bedrocks, whereas the differences in densities were smaller. Higher wood densities found on flysch in the subsample of pubescent oaks are likely an effect of higher proportions of latewood, while the opposite trend was observed in black pine. Higher wood density was found on limestone in black pine despite higher latewood percentages on flysch. In the context of forest management, the species composition of the naturally occurring mixtures in the sub-Mediterranean region should be adjusted slightly to favor pubescent oak, since it is a climax species and will bind more carbon for longer than black pine due to higher wood densities. Future forest management should also promote the overall development of pubescent oak trees in sub-Mediterranean stands. The results are especially important in the European context, because the share of sub-Mediterranean stands is expected to rise with global warming.
Ključne besede: Karst, wood structure, resistograph, resistance drilling, Quercus pubescens, Pinus nigra, limestone, flysch
Objavljeno v DiRROS: 14.01.2021; Ogledov: 1142; Prenosov: 397
.pdf Celotno besedilo (1,42 MB)
Gradivo ima več datotek! Več...

102.
Umerjanje rezistografskih meritev gostote lesa na stoječih drevesih : pretvorba v osnovno gostoto
Luka Krajnc, Polona Hafner, Jožica Gričar, Primož Simončič, 2020, drugi znanstveni članki

Povzetek: V prispevku predstavljamo proces in rezultate določitve korekcijskih količnikov za pretvorbo rezistografskih gostot, izmerjenih na stoječih drevesih, v osnovno gostoto lesa na primeru bukve (Fagus sylvatica L.), puhastega hrasta (Quercus pubescens Willd.) in črnega bora (Pinus nigraArnold.). Korekcijski količniki so bili določeni na podlagi sveže odžaganih kolutov, ki so bili povrtani z rezistografom. Kolute smo stehtali, izmerili njihovo prostornino ter jih posušili do absolutno suhega stanja. Iz zbranih podatkov smo nato izračunali osnovno gostoto lesa ter korekcijske količnike med osnovno in rezistografsko gostoto. V raziskavo je bilo zajetih 59 kolutov. Aritmetična sredina vseh izmerjenih količnikov znaša 1,41, vrednosti 95 % intervala zaupanja pa znašajo od 1,38 do 1,46. Razlike med drevesnimi vrstami so statistično neznačilne. Rezistografska gostota relativno dobro odraža osnovno gostoto kolutov (Pearsonov korelacijski koeficient = 0,91; p < 0,001), kar nakazuje na relativno dobro povezanost osnovnih gostot kolutov z rezistografskimi gostotami. Dobljeni rezultati so ključnega pomena za nadaljnji razvoj področja merjenja dejanskih gostot lesa v stoječih drevesih na hiter in relativno nedestruktiven način.
Ključne besede: rezistograf, gostota lesa, kakovost lesa, bukev, puhasti hrast, črni bor
Objavljeno v DiRROS: 14.12.2020; Ogledov: 1731; Prenosov: 481
.pdf Celotno besedilo (183,02 KB)

103.
Reproducibility of malignant pleural mesothelioma histopathologic subtyping
Luka Brčić, Gregor Vlačić, Franz Quehenberger, Izidor Kern, 2018, izvirni znanstveni članek

Povzetek: Context. Malignant pleural mesothelioma (MPM) is a rare tumor with poor prognosis. Several studies have analyzed potential prognostic markers, but histologic type remains the single most important prognostic factor. Histologic subtypes of epithelioid MPM seem to have prognostic and therapeutic implications. Interobserver agreement in histologic pattern classification should be high. Objective. To assess interobserver and intraobserver reproducibility in histologic differentiation between the main types of MPMs, and in further subtyping of epithelioid-type mesothelioma. Design. One representative hematoxylin-eosin-stained slide was selected from the archive for each of 200 patients with MPM. They were reviewed independently by 3 pathologists and classified according to the current World Health Organization classification of pleural tumors. After the first round of evaluations, a consensus meeting was organized where problems were addressed and representative images for each histologic category were selected. Two months later, cases were reevaluated by all 3 pathologists. Results. After the first round, overall interobserver agreement for histologic subtyping of mesothelioma was fair (k, 0.36). The agreement was increased to substantial (k, 0.63) in the second round. Improvement was found in interobserver agreement for all types of MPM, and for most epithelioid subtypes. Conclusions. Moderate to substantial agreement in histologic typing and subtyping of MPM can be achieved. However, training with additional clarification of diagnostic criteria, their strict application, and help from consensus-based illustrative images is needed.
Ključne besede: connective and soft tissue neoplasms -- pathology, malignant pleural mesothelioma, histopathology
Objavljeno v DiRROS: 30.11.2020; Ogledov: 5958; Prenosov: 456
URL Povezava na datoteko

104.
NSCLC molecular testing in Central and Eastern European countries
Ales Ryška, Peter Berzinec, Luka Brčić, Tanja Čufer, Rafal Dziadziuszko, Maya Gottfried, Ilona Kovalszky, Włodzimierz Olszewski, Buge Oz, Lukas Plank, József Tímár, 2018, izvirni znanstveni članek

Povzetek: Background: The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC) has highlighted the importance of accurate molecular diagnosis to determine if an actionable genetic alteration is present. Few data are available for Central and Eastern Europe (CEE) on mutation rates, testing rates, and compliance with testing guidelines. Methods: A questionnaire about molecular testing and NSCLC management was distributed to relevant specialists in nine CEE countries, and pathologists were asked to provide the results of EGFR and ALK testing over a 1-year period. Results: A very high proportion of lung cancer cases are confirmed histologically/cytologically (75-100%), and molecular testing of NSCLC samples has been established in all evaluated CEE countries in 2014. Most countries follow national or international guidelines on which patients to test for EGFR mutations and ALK rearrangements. In most centers at that time, testing was undertaken on request of the clinician rather than on the preferred reflex basis. Immunohistochemistry, followed by fluorescent in situ hybridization confirmation of positive cases, has been widely adopted for ALK testing in the region. Limited reimbursement is a significant barrier to molecular testing in the region and a disincentive to reflex testing. Multidisciplinary tumor boards are established in most of the countries and centers, with 75-100% of cases being discussed at a multidisciplinary tumor board at specialized centers. Conclusions: Molecular testing is established throughout the CEE region, but improved and unbiased reimbursement remains a major challenge for the future. Increasing the number of patients reviewed by multidisciplinary boards outside of major centers and access to targeted therapy based on the result of molecular testing are other major challenges.
Ključne besede: non-small-cell lung carcinoma, molecular diagnostic techniques, EGFR mutations, ALK rearrangements, Central Europe, Eastern Europe
Objavljeno v DiRROS: 30.11.2020; Ogledov: 1643; Prenosov: 918
.pdf Celotno besedilo (373,86 KB)
Gradivo ima več datotek! Več...

105.
106.
107.
Non-small cell lung cancer in countries of Central and Southeastern Europe : diagnostic procedures and treatment reimbursement surveyed by the Central European Cooperative Oncology Group
Ales Ryška, Rares Buiga, Albena Fakirova, Izidor Kern, Włodzimierz Olszewski, Lukas Plank, Sven Seiwerth, Erika Toth, Eri Zivka, Christiane Thallinger, Christoph Zielinski, Luka Brčić, 2018, izvirni znanstveni članek

Povzetek: This article analyzes the availability of different diagnostic procedures of non-small cell lung cancer (NSCLC) and the reimbursement landscape of drugs for NSCLC in countries of central and southeastern Europe (CEE). A survey was conducted by the Central European Cooperative Oncology Group. Results of the survey show that both availability and reimbursement of diagnoses of molecular alterations in NSCLC, the detection of which is essential for therapeutic decisions, varies widely between countries of CEE. Not only is "reflex" testing often substituted by analyses performed only "on demand," but reimbursement of such assessments varies widely between unavailability and payments by the health care system or even pharmaceutical companies. It was concluded that a structured access to testing and reimbursement should be the aim in order to provide patients with appropriate therapeutic options. Implications for Practice. This article provides an overview of the limitations in lung cancer treatment in countries of central and southeastern Europe, as well as the reimbursement status of various lung cancer treatment regimens in these countries, which directly impacts treatment options.
Ključne besede: Non-small cell lung carcinoma -- diagnosis -- economics -- Europe, molecular diagnostic techniques, precision medicine, Central Europe, Southeastern Europe, reimbursement
Objavljeno v DiRROS: 09.11.2020; Ogledov: 1508; Prenosov: 356
URL Povezava na datoteko

108.
109.
Lung cancer biomarker testing : perspective from Europe
Erik Thunnissen, Birgit Weynand, Dalma Udovicic-Gagula, Luka Brčić, Malgorzata Szolkowska, Paul Hofman, Silvana Smojver-Ježek, Sisko Anttila, Fiorella Calabrese, Izidor Kern, 2020, pregledni znanstveni članek

Povzetek: A questionnaire on biomarker testing previously used in central European countries was extended and distributed in Western and Central European countries to the pathologists participating at the Pulmonary Pathology Society meeting 26-28 June 2019 in Dubrovnik, Croatia. Each country was represented by one responder. For recent biomarkers the availability and reimbursement of diagnoses of molecular alterations in non-small cell lung carcinoma varies widely between different, also western European, countries. Reimbursement of such assessments varies widely between unavailability and payments by the health care system or even pharmaceutical companies. The support for testing from alternative sources, such as the pharmaceutical industry, is no doubt partly compensating for the lack of public health system support, but it is not a viable or long-term solution. Ideally, a structured access to testing and reimbursement should be the aim in order to provide patients with appropriate therapeutic options. As biomarker enabled therapies deliver a 50% better probability of outcome success, improved and unbiased reimbursement remains a major challenge for the future.
Ključne besede: lung neoplasms -- diagnosis -- therapy -- Europe, lung cancer, predictive testing
Objavljeno v DiRROS: 21.09.2020; Ogledov: 1657; Prenosov: 1064
.pdf Celotno besedilo (1,80 MB)
Gradivo ima več datotek! Več...

110.
Conceptual design of a decision support tool for severe accident management in nuclear power plants
Marko Bohanec, Ivan Vrbanić, Ivica Bašič, Klemen Debelak, Luka Štrubelj, 2019, objavljeni znanstveni prispevek na konferenci

Objavljeno v DiRROS: 10.09.2020; Ogledov: 1569; Prenosov: 407
.pdf Celotno besedilo (496,46 KB)

Iskanje izvedeno v 0.3 sek.
Na vrh